Livzon Pharmaceutical Group Inc. (1513.HK)
HKD 26.9
(-0.37%)
HKD 26.9
(-0.37%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.62 Billion CNY | -18.34% |
| 2022 | 1.98 Billion CNY | 209.33% |
| 2021 | 642.05 Million CNY | 73.33% |
| 2020 | 370.42 Million CNY | 0.0% |
| 2019 | - CNY | -100.0% |
| 2018 | 700 Thousand CNY | 0.0% |
| 2017 | 700 Thousand CNY | 0.0% |
| 2016 | 700 Thousand CNY | 0.0% |
| 2015 | 700 Thousand CNY | -99.85% |
| 2014 | 466.5 Million CNY | -15.17% |
| 2013 | 549.9 Million CNY | 78457.14% |
| 2012 | 700 Thousand CNY | -41.67% |
| 2011 | 1.2 Million CNY | -98.2% |
| 2010 | 66.79 Million CNY | -26.35% |
| 2009 | 90.7 Million CNY | -9.93% |
| 2008 | 100.7 Million CNY | 42.43% |
| 2007 | 70.7 Million CNY | -36.13% |
| 2006 | 110.7 Million CNY | 15714.29% |
| 2005 | 700 Thousand CNY | -99.22% |
| 2004 | 89.59 Million CNY | 258.36% |
| 2003 | 25 Million CNY | -65.03% |
| 2002 | 71.5 Million CNY | 12900.0% |
| 2001 | 550 Thousand CNY | -98.91% |
| 2000 | 50.52 Million CNY | -8.39% |
| 1999 | 55.14 Million CNY | 178.08% |
| 1998 | 19.83 Million CNY | -76.23% |
| 1997 | 83.43 Million CNY | 1.56% |
| 1996 | 82.15 Million CNY | 27286.47% |
| 1995 | 300 Thousand CNY | 100.0% |
| 1994 | 150 Thousand CNY | -94.0% |
| 1993 | 2.5 Million CNY | -84.03% |
| 1992 | 15.65 Million CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 864.4 Million CNY | -47.18% |
| 2024 Q3 | 410.75 Million CNY | -42.49% |
| 2024 Q2 | 722.05 Million CNY | -16.62% |
| 2023 Q2 | 2.63 Billion CNY | 17.73% |
| 2023 FY | 1.62 Billion CNY | -18.34% |
| 2023 Q4 | 1.62 Billion CNY | -33.47% |
| 2023 Q1 | 2.23 Billion CNY | 12.6% |
| 2023 Q3 | 2.43 Billion CNY | -7.41% |
| 2022 Q2 | 1.67 Billion CNY | 2.16% |
| 2022 Q3 | 1.78 Billion CNY | 6.84% |
| 2022 Q4 | 1.98 Billion CNY | 11.17% |
| 2022 FY | 1.98 Billion CNY | 209.33% |
| 2022 Q1 | 1.63 Billion CNY | 154.93% |
| 2021 Q4 | 642.05 Million CNY | -0.32% |
| 2021 Q3 | 644.14 Million CNY | -0.22% |
| 2021 FY | 642.05 Million CNY | 73.33% |
| 2021 Q2 | 645.54 Million CNY | 74.57% |
| 2021 Q1 | 369.79 Million CNY | -0.17% |
| 2020 Q2 | 1.00 CNY | 0.0% |
| 2020 Q1 | 1.00 CNY | 0.0% |
| 2020 FY | 370.42 Million CNY | 0.0% |
| 2020 Q3 | 1.00 CNY | 0.0% |
| 2020 Q4 | 370.42 Million CNY | 37042305100.0% |
| 2019 FY | - CNY | -100.0% |
| 2019 Q4 | - CNY | 0.0% |
| 2019 Q3 | - CNY | 0.0% |
| 2019 Q2 | - CNY | -100.0% |
| 2019 Q1 | 700 Thousand CNY | 0.0% |
| 2018 Q3 | 700 Thousand CNY | 0.0% |
| 2018 Q4 | 700 Thousand CNY | 0.0% |
| 2018 FY | 700 Thousand CNY | 0.0% |
| 2018 Q1 | 700 Thousand CNY | 0.0% |
| 2018 Q2 | 700 Thousand CNY | 0.0% |
| 2017 Q2 | 700 Thousand CNY | 0.0% |
| 2017 Q4 | 700 Thousand CNY | 0.0% |
| 2017 Q3 | 700 Thousand CNY | 0.0% |
| 2017 Q1 | 700 Thousand CNY | 0.0% |
| 2017 FY | 700 Thousand CNY | 0.0% |
| 2016 FY | 700 Thousand CNY | 0.0% |
| 2016 Q4 | 700 Thousand CNY | 0.0% |
| 2016 Q3 | 700 Thousand CNY | 0.0% |
| 2016 Q2 | 700 Thousand CNY | 0.0% |
| 2016 Q1 | 700 Thousand CNY | 0.0% |
| 2015 Q3 | 700 Thousand CNY | 0.0% |
| 2015 FY | 700 Thousand CNY | -99.85% |
| 2015 Q1 | 400.7 Million CNY | -14.11% |
| 2015 Q2 | 700 Thousand CNY | -99.83% |
| 2015 Q4 | 700 Thousand CNY | 0.0% |
| 2014 Q3 | 548.3 Million CNY | -0.15% |
| 2014 Q1 | 549.1 Million CNY | -0.15% |
| 2014 Q2 | 549.1 Million CNY | 0.0% |
| 2014 FY | 466.5 Million CNY | -15.17% |
| 2014 Q4 | 466.5 Million CNY | -14.92% |
| 2013 Q2 | 550.7 Million CNY | 265.43% |
| 2013 FY | 549.9 Million CNY | 78457.14% |
| 2013 Q4 | 549.9 Million CNY | 0.0% |
| 2013 Q1 | 150.7 Million CNY | 21428.57% |
| 2013 Q3 | 549.9 Million CNY | -0.15% |
| 2012 Q4 | 700 Thousand CNY | -41.67% |
| 2012 FY | 700 Thousand CNY | -41.67% |
| 2012 Q3 | 1.2 Million CNY | 0.0% |
| 2012 Q1 | 1.2 Million CNY | 0.0% |
| 2012 Q2 | 1.2 Million CNY | 0.0% |
| 2011 FY | 1.2 Million CNY | -98.2% |
| 2011 Q4 | 1.2 Million CNY | 0.0% |
| 2011 Q3 | 1.2 Million CNY | 0.0% |
| 2011 Q2 | 1.2 Million CNY | 0.0% |
| 2011 Q1 | 1.2 Million CNY | -98.2% |
| 2010 Q1 | 90.7 Million CNY | 0.0% |
| 2010 Q4 | 66.79 Million CNY | -36.01% |
| 2010 FY | 66.79 Million CNY | -26.35% |
| 2010 Q3 | 104.38 Million CNY | -1.34% |
| 2010 Q2 | 105.8 Million CNY | 16.65% |
| 2009 Q4 | 90.7 Million CNY | 12.39% |
| 2009 Q1 | 100.7 Million CNY | 0.0% |
| 2009 Q2 | 100.7 Million CNY | 0.0% |
| 2009 Q3 | 80.7 Million CNY | -19.86% |
| 2009 FY | 90.7 Million CNY | -9.93% |
| 2008 Q1 | 70.7 Million CNY | 0.0% |
| 2008 Q2 | 40.7 Million CNY | -42.43% |
| 2008 FY | 100.7 Million CNY | 42.43% |
| 2008 Q3 | 40.7 Million CNY | 0.0% |
| 2008 Q4 | 100.7 Million CNY | 147.42% |
| 2007 Q2 | 110.7 Million CNY | 0.0% |
| 2007 Q4 | 70.7 Million CNY | 0.0% |
| 2007 FY | 70.7 Million CNY | -36.13% |
| 2007 Q1 | 110.7 Million CNY | 0.0% |
| 2007 Q3 | 70.7 Million CNY | -36.13% |
| 2006 Q3 | 70.7 Million CNY | 130.29% |
| 2006 FY | 110.7 Million CNY | 15714.29% |
| 2006 Q4 | 110.7 Million CNY | 56.58% |
| 2006 Q2 | 30.7 Million CNY | 4285.71% |
| 2006 Q1 | 700 Thousand CNY | 0.0% |
| 2005 Q4 | 700 Thousand CNY | -99.21% |
| 2005 Q3 | 88.99 Million CNY | -0.11% |
| 2005 Q2 | 89.09 Million CNY | -1.11% |
| 2005 Q1 | 90.09 Million CNY | 0.56% |
| 2005 FY | 700 Thousand CNY | -99.22% |
| 2004 Q4 | 89.59 Million CNY | 0.0% |
| 2004 Q3 | - CNY | 0.0% |
| 2004 Q2 | - CNY | 0.0% |
| 2004 Q1 | - CNY | -100.0% |
| 2004 FY | 89.59 Million CNY | 258.36% |
| 2003 Q2 | 25 Million CNY | -65.03% |
| 2003 Q1 | 71.5 Million CNY | 0.0% |
| 2003 FY | 25 Million CNY | -65.03% |
| 2003 Q4 | 25 Million CNY | 0.0% |
| 2003 Q3 | 25 Million CNY | 0.0% |
| 2002 Q3 | 72.9 Million CNY | 0.0% |
| 2002 Q1 | 550 Thousand CNY | 0.0% |
| 2002 FY | 71.5 Million CNY | 12900.0% |
| 2002 Q2 | 72.9 Million CNY | 13154.55% |
| 2002 Q4 | 71.5 Million CNY | -1.92% |
| 2001 Q4 | 550 Thousand CNY | 0.0% |
| 2001 Q2 | 50.52 Million CNY | 0.0% |
| 2001 FY | 550 Thousand CNY | -98.91% |
| 2000 Q4 | 50.52 Million CNY | 0.0% |
| 2000 Q2 | 56.65 Million CNY | 0.0% |
| 2000 FY | 50.52 Million CNY | -8.39% |
| 1999 FY | 55.14 Million CNY | 178.08% |
| 1999 Q2 | 45.28 Million CNY | 0.0% |
| 1999 Q4 | 55.14 Million CNY | 0.0% |
| 1998 Q4 | 19.83 Million CNY | 0.0% |
| 1998 Q2 | 79.18 Million CNY | 0.0% |
| 1998 FY | 19.83 Million CNY | -76.23% |
| 1997 Q4 | 83.43 Million CNY | 0.0% |
| 1997 FY | 83.43 Million CNY | 1.56% |
| 1997 Q2 | - CNY | 0.0% |
| 1996 Q2 | - CNY | 0.0% |
| 1996 Q4 | 82.15 Million CNY | 0.0% |
| 1996 FY | 82.15 Million CNY | 27286.47% |
| 1995 Q4 | 300 Thousand CNY | 0.0% |
| 1995 FY | 300 Thousand CNY | 100.0% |
| 1995 Q2 | - CNY | 0.0% |
| 1994 Q4 | 150 Thousand CNY | 0.0% |
| 1994 Q2 | - CNY | 0.0% |
| 1994 FY | 150 Thousand CNY | -94.0% |
| 1993 FY | 2.5 Million CNY | -84.03% |
| 1992 FY | 15.65 Million CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 2.07 Million HKD | -78134.669% |
| Grand Pharmaceutical Group Limited | 990.02 Million HKD | -63.814% |
| Extrawell Pharmaceutical Holdings Limited | 117.12 Million HKD | -1284.69% |
| Wai Yuen Tong Medicine Holdings Limited | 276.2 Million HKD | -487.185% |
| Qianhai Health Holdings Limited | - HKD | -Infinity% |
| Lee's Pharmaceutical Holdings Limited | 70.63 Million HKD | -2196.002% |
| Essex Bio-Technology Limited | 36.05 Million HKD | -4397.923% |
| Tongfang Kontafarma Holdings Limited | 12.8 Million HKD | -12569.353% |
| PuraPharm Corporation Limited | 81.09 Million HKD | -1899.931% |
| SSY Group Limited | 1.94 Billion HKD | 16.727% |
| JBM (Healthcare) Limited | 43.8 Million HKD | -3602.749% |
| Jacobson Pharma Corporation Limited | 592.2 Million HKD | -173.861% |
| China Resources Pharmaceutical Group Limited | 16.61 Billion HKD | 90.24% |